Compass Pathways Plc (CMPS)
11.62
+0.35
(+3.11%)
USD |
NASDAQ |
Oct 15, 16:00
11.63
+0.01
(+0.09%)
After-Hours: 20:00
Compass Pathways Cash from Operations (TTM) : -160.76M for June 30, 2026
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -160.76M |
| March 31, 2026 | -159.63M |
| December 31, 2025 | -157.61M |
| September 30, 2025 | -161.34M |
| June 30, 2025 | -149.05M |
| March 31, 2025 | -144.25M |
| December 31, 2024 | -119.24M |
| September 30, 2024 | -105.63M |
| June 30, 2024 | -101.11M |
| March 31, 2024 | -91.08M |
| December 31, 2023 | -97.75M |
| September 30, 2023 | -115.23M |
| Date | Value |
|---|---|
| June 30, 2023 | -114.33M |
| March 31, 2023 | -107.81M |
| December 31, 2022 | -103.31M |
| September 30, 2022 | -80.23M |
| June 30, 2022 | -77.11M |
| March 31, 2022 | -76.90M |
| December 31, 2021 | -67.74M |
| September 30, 2021 | -62.23M |
| June 30, 2021 | -62.17M |
| March 31, 2021 | -50.74M |
| December 31, 2020 | -41.38M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Silence Therapeutics Plc | -41.79M |
| Biodexa Pharmaceuticals Plc | -9.219M |
| NuCana Plc | -6.332M |
| Mereo BioPharma Group Plc | -25.28M |
| HemoGenyx Pharmaceuticals Plc | -1.937M |